Turbine, a leading developer of cell simulations with AI, announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ...
Turbine has successfully completed the first phase of its oncology target identification and validation collaboration with Ono
Turbine, the biological simulation company using AI to...
Companies will co-develop inhibitors of a dark kinase target (NEK1) identified for cancer dependency by Turbine’s Simulated Cell™ platform
Turbine, a company that is building the...